Bioclindavet 75 mg chewable tablet for dogs
Bioclindavet 75 mg chewable tablet for dogs
Authorised
- Clindamycin hydrochloride
Product identification
Medicine name:
Bioclindavet 75 mg chewable tablet for dogs
Active substance:
- Clindamycin hydrochloride
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin hydrochloride81.44/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Cardboard box of 10 tablets (1 blisters of 10 tablets)
- Cardboard box of 30 tablets (3 blisters of 10 tablets)
- Cardboard box of 100 tablets (10 blisters of 10 tablets)
- Cardboard box of 250 tablets (25 blisters of 10 tablets)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Axience
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA22873/004/001
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0483/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Germany
-
Ireland
-
Italy
-
Netherlands
-
Romania
-
Slovakia
-
Spain
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
